Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy

This publication has 28 references indexed in Scilit:

• Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results
  Radiotherapy and Oncology, 2003
• A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Inverse Treatment Planning and Stereotactic Intensity-Modulated Radiation Therapy (IMRT) of the Tumor and Lymph Node Levels for Nasopharyngeal Carcinomas
  Strahlentherapie und Onkologie, 2002
• A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California–San Francisco experience
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Parotid gland sparing in patients undergoing bilateral head and neck irradiation: Techniques and early results
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck Cancer
  New England Journal of Medicine, 1993
• A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
  Journal of Clinical Oncology, 1993